Guru Ownership Trend
Guru Analysis for Abbott Laboratories (ABT)
Abbott Laboratories (ABT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 19 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.87 B.
Top institutional holders include Jeremy Grantham and Diamond Hill Capital.
Institutional sentiment is currently Bearish. This is evidenced by a $686.83 M net outflow during the quarter.
Recent activity highlights Jefferies Group who increased their stake by 154.8%. Conversely, Ken Fisher reduced exposure by 93.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Abbott Laboratories (ABT)
Major holders include Jeremy Grantham ($914.89 M), Diamond Hill Capital ($552.25 M), Lee Ainslie ($180.51 M). According to the latest reported data, 19 tracked investment managers collectively hold approximately 21.44 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $686.83 M, with 13 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 4 managers trimmed their positions, while 0 fully exited ABT. The total reported sell value was $1.1 B.
Yes, 2 managers opened new positions in ABT, and 11 increased their existing holdings. The total reported buy value was $411.15 M.
